The trials in the first and second phases had led to promising results.
Drug developer Ocugen Inc will co-develop Hyderabad-based Bharat Biotech’s COVID-19 vaccine candidate for the US market, the companies said on Tuesday.
The vaccine candidate, Covaxin, is currently in a late-stage study in India.